Johnson & Johnson (JNJ) Beats the Street
Health care products maker Johnson & Johnson on Tuesday posted a fourth-quarter profit increase of nearly 10 percent as revenues jumped by double digits despite declines in sales of two key product lines.
The New Brunswick, N.J.-based maker of prescription drugs, medical devices, contact lenses and baby care items reported net income of $2.37 billion, or 82 cents per share, up from $2.17 billion, or 74 cents per share, a year earlier.
Excluding one-time items, net income would have been 88 cents per share.
Revenues totaled $15.96 billion, up 16.6 percent from $2.17 billion in the year-ago quarter.
Analysts surveyed by Thomson Financial were expecting earnings of 86 cents per share on revenues of $15.4 billion in the latest period. The estimates typically exclude one-time items.
The New Brunswick, N.J.-based maker of prescription drugs, medical devices, contact lenses and baby care items reported net income of $2.37 billion, or 82 cents per share, up from $2.17 billion, or 74 cents per share, a year earlier.
Excluding one-time items, net income would have been 88 cents per share.
Revenues totaled $15.96 billion, up 16.6 percent from $2.17 billion in the year-ago quarter.
Analysts surveyed by Thomson Financial were expecting earnings of 86 cents per share on revenues of $15.4 billion in the latest period. The estimates typically exclude one-time items.
Labels: JNJ, Johnson and Johnson
posted by Stock Administrator @ 9:55 AM
0 Comments:
Post a Comment
<< Home